← All indications
Bronchiolitis Obliterans
Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA.
Subtype terms (1)
More specific conditions that are subtypes of Bronchiolitis Obliterans in the MeSH hierarchy.
Drugs by status
Phase 4 trials (4)
Phase 3 trials (6)
Phase 2 trials (9)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (20)
- Incyte
- AstraZeneca
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
- Harvard University
- University of Washington
- Northwestern University
- The Canadian Blood and Marrow Transplant Group
- University of Maryland
- University of Michigan
- University of Regensburg
- University of Cincinnati
- University of Basel
- Food and Drug Administration
- Southern Medical University
- Sun Yat-Sen University
- University of Montreal
- Paris Diderot University
- ClinAssess GmbH
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (7)